| Device |
adalimumab assay |
| Definition |
An in vitro diagnostic device intended for the measurement of adalimumab, an anti-tumor necrosis factor alpha monoclonal antibody |
| Physical State |
Solid, dry reagent pack liquid reagents and liquid control solutions |
| Technical Method |
Time-resolved fluorescence energy transfer immunoassay |
| Target Area |
Serum |
| Regulation Medical Specialty |
Toxicology |
| Review Panel |
Toxicology |
| Product Code | QYD |
| Premarket Review |
Division of Chemistry and Toxicology Devices
(DCTD)
Division of Chemistry and Toxicology Devices
(DCTD)
|
| Submission Type |
510(k)
|
| Regulation Number |
862.3115
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |
|
|